Webinar
Navigating regulatory pathways in the US for Cell and Gene Therapy
calendar

October 28, 2021

Calendar
clock

11:00am - 12:30pm

(GMT+9:00)

WATCH ON-DEMAND

View all IQVIA events

In recent years, Cell and Gene Therapies (CAGT) has seen tremendous growth in the Japan and Asia Pacific (JAPAC) region with a continually increasing number of biopharmaceutical companies initiating clinical trials with their innovative therapies.

As these Asia Pacific-originated programs progress, to maximize their return on investment, companies are beginning to look for ways to expand development and registration of their assets to the United States, the world's largest healthcare market.

Watch our on-demand webinar to discover how IQVIA can help you navigate the US FDA regulations of regenerative medicine therapies, take advantage of expedited programs and proactively address Chemistry, Manufacturing and Controls (CMC) considerations and ultimately increase the probability of your success.



Speakers

Monica R. Shah, MD, FACC
Vice President and Head, Cell and Gene Therapy Center of Excellence
IQVIA

Hardeep Samra
Sr. Director, Head of Regulatory Strategy, Strategic Drug Development
IQVIA

Eugene Brandon
Sr. Director and Head of Translation, Cell and Gene Therapy
IQVIA

Susan McClatchey
Sr. Director Product Development, Cell and Gene Therapy
IQVIA

Kristin Baird, MD
Medical Strategy Lead, Cell and Gene Therapy
IQVIA

Contact Us